Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak

J Am Coll Surg. 2007 Oct;205(4):527-33. doi: 10.1016/j.jamcollsurg.2007.07.026.

Abstract

Background: The dual actions of angiotensin II (AngII) on microvascular fluid leak remain enigmatic. Our hypothesis was that the AngII type 2 (AT2) receptor decreases microvascular fluid leak during inflammation. The purposes of this study were to determine the activity of the AT2 receptor during stimulation by endogenous AngII, during stimulation by exogenous AngII, and during inflammation.

Study design: Hydraulic permeability (L(p)) of rat mesenteric venules was measured using a microcannulation technique. L(p) was measured during perfusion with the AT1 receptor antagonist, ZD7155, and also with exogenous AngII during AngII type 1 receptor (AT1) blockade. Inflammation was induced with platelet activating factor (PAF), and L(p) was measured during perfusion of AngII with AT1 blockade and also with an AT2 receptor agonist, CGP42112.

Results: AT2 receptor activation by endogenous AngII slightly decreased L(p) over that of the control (p=0.02). Exogenous AngII increased L(p) fivefold (L(p)=4.83+/-1.32; p < 0.001). Addition of AT1 receptor blockade decreased L(p) by 74% (to 1.24+/-0.03; p < 0.01). PAF activation increased L(p) fourfold (L(p)=4.49+/-0.74; p < 0.0001). After PAF activation, exogenous AngII then decreased L(p) by 39% (to 2.74+/-0.12; p < 0.01). Exogenous AngII during AT1 receptor blockade after PAF activation decreased L(p) by 61% (from 4.49+/-0.74 to 1.77+/-0.22; p < 0.0001), and selective AT2 receptor stimulation after PAF activation decreased L(p) by 69% (from 4.49+/-0.74 to 1.40+/-0.04; p < 0.001).

Conclusions: This study further supports a dual role for AngII. AngII increases microvascular fluid leak during basal conditions but appears to decrease it during inflammation. Alterations in AT2 receptor activity may be responsible for these different effects.

MeSH terms

  • Angiotensin II / pharmacology
  • Angiotensin II / physiology*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Capillary Permeability / drug effects
  • Capillary Permeability / immunology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology*
  • Female
  • Inflammation / physiopathology
  • Mesenteric Veins / drug effects
  • Mesenteric Veins / physiopathology*
  • Microcirculation / immunology*
  • Models, Animal
  • Oligopeptides / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 2 / agonists
  • Receptor, Angiotensin, Type 2 / immunology
  • Receptor, Angiotensin, Type 2 / physiology*
  • Vascular Diseases / immunology*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Oligopeptides
  • Receptor, Angiotensin, Type 2
  • Angiotensin II
  • CGP 42112A